Synthesis, Anticancer and Radioprotective Activities of Some New Pyrazolo[3,4-d]pyrimidines Containing Amino Acid Moieties

Mostafa M Ghorab; Fatma A Ragab; Eman Noaman; Helmy I. Heiba; Sarah A. Aboulmagd

doi:10.1055/s-0031-1296370

Arzneimittelforschung, Table of Contents

Arzneimittelforschung 2009; 59(2): 96-103
DOI: 10.1055/s-0031-1296370

Antibiotics · Antimycotics · Antiparasitics · Antiviral Drugs · Chemotherapeutics · Cytostatics

Editio Cantor Verlag Aulendorf (Germany)

Synthesis, Anticancer and Radioprotective Activities of Some New Pyrazolo[3,4-d]pyrimidines Containing Amino Acid Moieties

Authors

Mostafa M Ghorab

¹Department of Drug Radiation Research, National Centre for Radiation Research and Technology, Atomic Energy Authority, Nasr City, Cairo, (Egypt)
Fatma A Ragab

²Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Cairo, (Egypt)
Eman Noaman

³Department of Radiation Biology, National Centre for Radiation Research and Technology, Atomic Energy Authority, Nasr City, Cairo, (Egypt)
Helmy I. Heiba

¹Department of Drug Radiation Research, National Centre for Radiation Research and Technology, Atomic Energy Authority, Nasr City, Cairo, (Egypt)
Sarah A. Aboulmagd

¹Department of Drug Radiation Research, National Centre for Radiation Research and Technology, Atomic Energy Authority, Nasr City, Cairo, (Egypt)

Abstract

Various isomeric structural purine analogues possessing the pyrazolo[3,4-d]pyrimidine nucleus bearing amino acid moieties have been synthesized. The structures of the synthesized compounds were elucidated by spectral data. Preliminary testing for in vitro anticancer activity of the synthesized compounds against Ehrlich ascites carcinoma cells was carried out.

2-(1-Phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-ylamino)-propanoic acid (3b), 4-methyl-2-(1-phenyl-1H-pyrazolo[3,4-d] pyrimidin-4-ylamino)-pentanoic acid (3d), 4-methylthio-2-( 1-phenyl- 1H-pyra-zolo[3,4-d] pyrimidin-4-ylamino)-butanoic acid (3e) and phenyl-2-(1-phenyl-1H-pyrazolo[3,4-d] pyrimidin-4-ylamino)-propanoic acid (3f) were the most active compounds. Moreover, compounds 3e and 1-( 1-phenyl-1H-pyrazolo[3,4-d] pyrimidin-4-yl)-pyrrolidine-2-carboxylic acid (4) exhibited significant in vivo radioprotective activity.

Key words

Anticancer agents - Pyrazolo[3,4-d]pyrimidines, amino acid side chains - anticancer activity, radioprotective activity, synthesis

Full Text

References

References
1 Legraverend M, Grierson DS. The purines: Potent and versatile small molecule inhibitors and modulators of key biological targets. Bioorg Med Chem. 2006; 14 (12) 3987-4006
2 Block JH, Beale JM. Wilson and Gisvold’s textbook of Organic Medicinal and Pharmaceutical Chemistry. 11^th ed. Philadelphia (PA, USA): Lippincott Williams & Wilkins; 2004
3 Petrie III CR, Cottam HB, McKeman PA, Robins RK, Revankar GR. Synthesis and biological activity of 6-azacadeguomycin and certain 3,4,6-trisubstituted pyrazolo[3,4-d]pyrimidine ribonucleosides. J Med Chem. 1985; 28 (8) 1010-6
4 Bhat GA, Montero JLG, Panzica RP, Wotring LL, Tow-send LB. Synthesis and biological activity of certain pyra-zolo[3,4-d]pyrimidine nucleosides related to adenosine. J Med Chem. 1981; 24 (10) 1165-72
5 Zacharie B, Connolly TP, Rej R, Attardo G, Penney CL. A short synthesis of substituted l-(hydroxyalkyl)-1H-pyrazo-lo[3,4-d]pyrimidines. Tetrahedron. 1996; 52 (7) 2271-8
6 Kim DC, Lee YR, Yang B, Shin KJ, Kim DJ, Chung BY et al Synthesis and biological evaluations of pyrazolo[3,4-d]pyr-imidines as cyclin-dependent kinase 2 inhibitors. Eur J Med Chem. 2003; 38 (5) 525-32
7 Schenone S, Bruno O, Bondavalli F, Ranise A, Mosti L, Menozzi G et al Antiproliferative activity of new 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives toward the human pidermoid carcinoma A431 cell line. Eur J Med Chem. 2004; 39 (11) 939-46
8 Gupta S, Rodrigues LM, Esteves AP, Oliveira-Campos AMF, Nascimento MSJ, Nazareth N et al Synthesis of N-aryl-5-amino-4-cyanopyrazole derivatives as potent xanthine oxidase inhibitors. Eur J Med Chem. 2008; 43 (4) 771-80
9 Davies LP, Brown DJ, Chow SC, Johnston GAR. Pyrazolo [3,4-d] pyrimidines, a new class of adenosine antagonists. Neurosci. Lett. 1983; 41 (1–2) 189-93
10 Heiba HI, Ghorab MM, El-Gawish MA. Biological and biochemical screening of some new amino acid thienopyrimidinone derivatives for potential radioprotective character. Phosphorus Sulfur Silicon. 1997; 131: 197-205
11 Ghorab MM, Noaman E, Ismail MMF, Heiba HI, Ammar YA, Sayed MY. Novel antitumor and radioprotective sulfonamides containing pyrrolo[2,3-d]pyrimidines. Arzneimittelforschung. 2006; 56 (6) 405-13
12 Ismail MMF, Ghorab MM, Noaman E, Ammar YA, Heiba HI, Sayed MY. Novel synthesis of pyrrolo[2,3-d]pyrimidines bearing sulfonamide moieties as potential antitumor and radioprotective agents. Arzneimittelforschung. 2006; 56 (4) 301-8
13 Ghorab MM, Ragab FA, Noaman E, Heiba HI, Galal M. Synthesis of certain new thieno[2,3-d]pyrimidines as potential antitumor and radioprotective agents. Arzneimittelforschung. 2006; 56 (7) 553-60
14 Heiba HI, Ragab FA, Noaman E, Ghorab MM, Galal M. Synthesis of some novel sulphur containing triazolothienopyrimidines and biscompounds as possible antitumor and radioprotective agents. Arzneimittelforschung. 2006; 56 (8) 593-9
15 Ghorab MM, Osman AN, Noaman E, Heiba HI, Zaher NH. The synthesis of some new sulfur heterocyclic compounds as potential radioprotective and anticancer agents. Phosphorus Sulfur Silicon. 2006; 181: 1935-50
16 Ghorab MM, Osman AN, Noaman E, Heiba HI, Zaher NH. The utility of isothiocyanato thiophenes in synthesis of thieno[2,3-d]pyrimidine derivatives as possible radioprotective and anticancer agents. Phosphorus Sulfur Silicon. 1996; 181: 1983-96
17 Abou El Ella DA, Ghorab MM, Noaman E, Heiba HI, Khalil AI. Molecular modeling study and synthesis of novel pyrrolo[2,3-d]pyrimidines and pyrrolotriazopyrimidines of expected antitumor and radioprotective activities. Bioorg Med Chem. 2008; 16 (5) 2391-402
18 Sugimoto O, Mori M, Tanji KA. facile halogenation of some hydroxyheterocycles using triphenylphosphine and N-halosuccinimide Tetrahedron Lett. 1999; 40 (42) 7477-8
19 Sarangan S, Somasekhara S. Synthesis of some derivatives of pyrazolo[3,4-d]pyrimidine-4,6-diones. J Indian Chem Soc. 1976; 53 (4) 426-7
20 Brusick DJ. Cytogenetic assays, aberrations and SCE techniques in carcinogenesis and mutagenesis testing. Clifton (New Jersey, USA): Human Press Inc.; 1984: 265-76
21 Yoshioka T, Kawada K, Shimada T, Mori M. Lipid peroxidation in maternal and cord blood and protective mechanism against activated oxygen toxicity in the blood. Am J Obstet Gynecol. 1979; 135: 372-6
22 Beutler E, Duron O, Kelly DM. Improved method of the determination of blood glutathione. J Lab Clin Med. 1963; 61 (5) 882-8
23 Minami M, Yoshikawa HA. simplified assay method of superoxide dismutase. Clin Chim Acta. 1979; 92: 337-42
24 Snedecor GW, Cochron WG. Statistical methods. 8th ed. Ames (Iowa, USA): Louis State University Press; 1989
25 Bellamy L. The infrared spectra of complex molecules. New York: Wiley; 1975
26 Afifiy AA, El-Nagdy S, Sayed MA, Mohey I. Synthesis and reactions of substituted benzoxazinones bearing a bulky group at position-2. Ind J Chem. 1988; 27B (B(10)) 920-5
27 Sohal RS, Weindruch R. Oxidative stress, caloric restriction and aging. Science. 1996; 273: 59-63
28 Beckman KB, Ames BM. The free radical theory of aging matures. Physiol Rev. 1998; 78: 547-81
29 Bonnefont D, Rousselot J. Irrradiation of cell membranes. J Chim Phys Physico chim Biol. 1994; 91: 968-83
30 Tenchova V. Acute gamma irradiation effect on lipid oxidation and antioxidant activity in rat hemopoietic organs and plasma. Rentgenologiya IRadiologiya. 1994; 33 (4) 49-54